Donor Spotlight: Initiatives Made Possible by Movember

Thanks to the support all of the Mo Bros and Mo Sistas, we’re excited to announce some new initiatives made possible by your funding achievements.

Of the $42 million raised by 2011 Movember participants, $32.8 million was directed towards PCC projects. Already $3.2 million of this amount has been invested in research and support services, such as Clinician Scientist awards, Pilot Grants and A Survivorship Action Partnership (ASAP). For details on prostate cancer programs run by the Movember foundation and a full breakout of cost, please visit

We plan to have committed an additional $22M to research and survivorship projects in the summer of 2013 through these new initiatives with the remainder of the 2011 Movember revenue fully committed to projects later in the fall subject to the quality of applications received.

Careful strategic planning will continue to ensure that your donor dollars are spent wisely on the most promising projects in Canada, as outlined in our Research Strategic Plan. Examples include the Movember Team Grants and Rising Star in Prostate Cancer Research programs.

These charts show planned expenditures on programs. They are subject to some modification based on PCC Board approval as well as the number and quality of submissions received in each category. Discovery Grants and Rising Star Awards were formerly known as Pilot Grants and Clinician Scientist Awards respectively.

A Survivorship Action Partnership
Other Survivorship Projects
Discovery Grants
Rising Star Awards
Team Grants
Clinical Trial Program
Research Requests for Applications
Health Education Technology
Integrated Supportive Care Service

More Information:
Ethics & Accountability
Privacy Policy

Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
Advancements In Prostate Cancer Research and Support Are Made in Movember

TORONTO, December 2, 2014 - Prostate Cancer Canada congratulates Movember on successfully raising more than $20 million this year. More

Prostate cancer researchers develop personalized genetic test to accurately predict recurrence risk

TORONTO, ON - November 13, 2014 – Prostate cancer researchers have developed a genetic test to identify which men are at highest risk for their prostate cancer to come back after localized treatment with surgery or radiotherapy. More

Click here for news archive